B3 Pinpointing precision medicine

Wednesday 31 August 2016
Hilton Buenos Aires : Atlantico C

Organised by the FIP Special Interest Group on Translational Research and Individualized


Simultaneous translation in Spanish


To provide optimal patient care, pharmacists must reduce the ongoing burden of disease by mitigating adverse drug reactions, therapeutic failures and poor adherence. In this new age of precision medicine, treatments and prevention efforts are strongly enhanced by available pharmacogenomics technology, so pharmacists must learn to use this technology to improve patient care. This session will give an update on what is new in the field of precision medicine. What should be known by practising pharmacists? What are the challenges in research, implementation and ethics?

Learning objectives

At the conclusion of this application-based session, participants will be able to:

  1. Evaluate the current state of the field of precision medicine, not just considering pharmacogenetics but also other “-omics” techniques
  2. Analyse how pharmacogenomics can improve the quality of patient care
  3. Investigate the challenges in implementing precision medicine, and how can we meet them
  4. Demonstrate the educational approaches that pharmacists and other health care professionals should consider to be able to use pharmacogenomic information effectively. 


Susanne Vijverberg (Utrecht University, Netherlands) and Christina Aquilante (University of Colorado, USA) 




1)      Precision medicine: More than pharmacogenetics

Colin Palmer (University of Dundee, UK)


2)      Clinical value of precision medicine in paediatrics

Susanne Vijverberg (Utrecht University, Netherlands)

10:20 – 10:40 Coffee/tea break


3)      Clinical value of precision medicine in oncology: The tumour perspective

Ross McKinnon (University of South Australia, Australia)


4)      Educational approaches for today and tomorrow: Preparing pharmacists for precision medicine

Christina Aquilante (University of Colorado, USA)